Patent · US Active

Methods of treatment and pharmaceutical composition

US8404744B2 · kind B2 · utility

1Cited by

0References

10Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Gary Michael Ksander · Carmel, US
Randy Lee Webb · Flemington, US

Key dates

Filing date	Dec 16, 2011
Grant date	Mar 26, 2013
Priority date	—
Expiry date	Dec 16, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates a pharmaceutical composition comprising a combination of (i) the AT 1-antagonist valsartan or a pharmaceutically acceptable salt thereof and (ii) a NEP inhibitor or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier and to a method for the treatment or prevention of selected conditions or diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.